Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer
NCT07386639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19019
Last updated 2026-02-04
Summary
This study looked at whether male and female patients with liver cancer (hepatocellular carcinoma, HCC) have different risks of the cancer spreading to distant parts of the body (distant metastasis). Liver cancer is much more common in men than in women, and women often have better survival rates. However, it was unclear if the factors that predict this spread are the same for both sexes.
To answer this question, researchers analyzed information from a large, national cancer database (SEER) from 2004 to 2022, including 19,019 patients diagnosed with liver cancer. They studied factors like age, race, tumor stage, treatment received, and where patients lived. The team used advanced computer models (machine learning) to build separate prediction tools for men and women to estimate their risk of distant metastasis at the time of diagnosis.
Conditions
- Hepatocellular Carcinoma
- Liver Cancer
- Neoplasm Metastasis
Sponsors & Collaborators
-
Tongji University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-01
- Primary Completion
- 2023-01-31
- Completion
- 2025-12-31
More Related Trials
-
The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
NCT06977399 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735 ·Status: UNKNOWN
-
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
NCT06653478 ·Status: RECRUITING
-
The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells
NCT04568720 ·Status: UNKNOWN
-
Biomarker Discovery and Validation in Lung Cancer
NCT01147562 ·Status: UNKNOWN ·Phase: NA
-
CT Body Composition Enhances Survival Risk Stratification
NCT07109271 ·Status: COMPLETED
-
Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology
NCT06810349 ·Status: RECRUITING
-
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
NCT04745715 ·Status: COMPLETED
-
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer(NSCLC)
NCT07388771 ·Status: RECRUITING
-
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
NCT05426135 ·Status: RECRUITING
-
Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma
NCT06623474 ·Status: RECRUITING
-
Explainable Machine Learning for Predicting Early Gastric Cancer
NCT07047937 ·Status: ENROLLING_BY_INVITATION
-
Contrast Between Traditional Regression Model and AI in Predicting Prolonged Stay Stay After Head and Neck Tumors
NCT06570486 ·Status: RECRUITING
-
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344 ·Status: COMPLETED
-
Noninvasive Intratumor Heterogeneity Evaluation in HNSCC
NCT07027280 ·Status: RECRUITING
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
NCT06735118 ·Status: RECRUITING ·Phase: NA
-
Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
NCT07050576 ·Status: RECRUITING
-
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
NCT05721963 ·Status: UNKNOWN
-
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
NCT06557967 ·Status: COMPLETED
-
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473 ·Status: RECRUITING
-
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
NCT07287904 ·Status: NOT_YET_RECRUITING
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy
NCT06285058 ·Status: NOT_YET_RECRUITING
-
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
NCT04442425 ·Status: COMPLETED